Literature DB >> 23063712

Targeting the mitochondrial electron transport chain in autism, a systematic review and synthesis of a novel therapeutic approach.

Ahmad Ghanizadeh1, Michael Berk, Hassan Farrashbandi, Ali Alavi Shoushtari, Kristi-Ann Villagonzalo.   

Abstract

Autism is a complex developmental disorder with an unknown etiology and without any curative treatment. The mitochondrial electron transfer chains play a major role in the production of ATP, and the generation and management of reactive oxidative stress (ROS). This paper is a systematic review of the role of the mitochondrial electron transport chain in autism, and a consequent hypothesis for treating autism is synthesized. An electronic search with pre-specified inclusion criteria was conducted in order to retrieve all the published articles about the mitochondrial electron transport chain in autism. The two databases of PUBMED and Google Scholar were searched. From one hundred twenty five retrieved titles, 12 (three case control study and 9 case reports) articles met inclusion criteria. All of the included studies indicated dysfunction of electron transport chain in autism. The mitochondrial electron transfer chain seems impaired in some children with autism and ROS production is additionally enhanced. It is hypothesized that interventions involving alternative electron shuttling may improve autism through lowering the production of ROS. In addition, it is expected that this alternative electron shuttling to cytochrome c might enhance the production of ATP which is impaired in the disorder.
Copyright © 2012 Elsevier B.V. and Mitochondria Research Society. All rights reserved. All rights reserved.

Entities:  

Keywords:  Autism; Energy; Etiology; Mitochondria; Oxidative stress; Treatment

Mesh:

Substances:

Year:  2012        PMID: 23063712     DOI: 10.1016/j.mito.2012.10.001

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  11 in total

1.  A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.

Authors:  Ahmad Ghanizadeh; Aliakbar Sahraeizadeh; Michael Berk
Journal:  Child Psychiatry Hum Dev       Date:  2014

Review 2.  Preeclampsia and Neurodevelopmental Outcomes: Potential Pathogenic Roles for Inflammation and Oxidative Stress?

Authors:  Aaron Barron; Cathal M McCarthy; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2021-01-25       Impact factor: 5.590

3.  Novel interactive partners of neuroligin 3: new aspects for pathogenesis of autism.

Authors:  Chen Shen; Li-rong Huo; Xin-liang Zhao; Pei-rong Wang; Nanbert Zhong
Journal:  J Mol Neurosci       Date:  2014-12-03       Impact factor: 3.444

4.  High KEAP1, NRF2 and Low HO-1 Serum Levels in Children with Autism.

Authors:  Hamza Ayaydin; İsmail Akaltun; İsmail Koyuncu; Hakim Çelİk; Adnan Kİrmİt; Hatice Takatak
Journal:  Noro Psikiyatr Ars       Date:  2020-09-21       Impact factor: 1.339

5.  A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.

Authors:  Ahmad Ghanizadeh; Ebrahim Moghimi-Sarani
Journal:  BMC Psychiatry       Date:  2013-07-25       Impact factor: 3.630

Review 6.  Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.

Authors:  Joel R Frandsen; Prabagaran Narayanasamy
Journal:  Redox Biol       Date:  2017-10-18       Impact factor: 11.799

7.  Elucidating Conserved Transcriptional Networks Underlying Pesticide Exposure and Parkinson's Disease: A Focus on Chemicals of Epidemiological Relevance.

Authors:  Fangjie Cao; Christopher L Souders Ii; Veronica Perez-Rodriguez; Christopher J Martyniuk
Journal:  Front Genet       Date:  2019-01-25       Impact factor: 4.599

8.  Selective Mitochondrial Targeting Exerts Anxiolytic Effects In Vivo.

Authors:  Markus Nussbaumer; John M Asara; Larysa Teplytska; Michael P Murphy; Angela Logan; Christoph W Turck; Michaela D Filiou
Journal:  Neuropsychopharmacology       Date:  2015-11-16       Impact factor: 7.853

9.  Ubiquinol improves symptoms in children with autism.

Authors:  Anna Gvozdjáková; Jarmila Kucharská; Daniela Ostatníková; Katarína Babinská; Dalibor Nakládal; Fred L Crane
Journal:  Oxid Med Cell Longev       Date:  2014-02-23       Impact factor: 6.543

10.  Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.

Authors:  George Anderson; Michael Maes
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.